Björn Gregertsen

Björn is vice president of the department Chemical Process and Pharmaceutical Development. The department provides expertise in process development in commercial collaborations as well as grant financed research. A key focus is pharmaceutical synthesis and formulation including GMP manufacture for clinical trials. The department also has significant expertise in process development of biobased chemicals and provides development services in several other fields where fundamental understanding of chemistry, formulation and process development is relevant. Björn has worked with process development for most of his career both in industry and at RISE.